DE60002719D1 - Ophthalmische zusammensetzungen in form wässriger gele - Google Patents

Ophthalmische zusammensetzungen in form wässriger gele

Info

Publication number
DE60002719D1
DE60002719D1 DE60002719T DE60002719T DE60002719D1 DE 60002719 D1 DE60002719 D1 DE 60002719D1 DE 60002719 T DE60002719 T DE 60002719T DE 60002719 T DE60002719 T DE 60002719T DE 60002719 D1 DE60002719 D1 DE 60002719D1
Authority
DE
Germany
Prior art keywords
aqueous gels
ophthalmic compositions
gels
aqueous
solubilising
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60002719T
Other languages
English (en)
Other versions
DE60002719T2 (de
Inventor
Marco Sanso'
Renato Sebben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FARMILA FARMA MILANO
Original Assignee
FARMILA FARMA MILANO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FARMILA FARMA MILANO filed Critical FARMILA FARMA MILANO
Application granted granted Critical
Publication of DE60002719D1 publication Critical patent/DE60002719D1/de
Publication of DE60002719T2 publication Critical patent/DE60002719T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60002719T 1999-07-01 2000-06-29 Ophthalmische zusammensetzungen in form wässriger gele Expired - Lifetime DE60002719T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001453A ITMI991453A1 (it) 1999-07-01 1999-07-01 Composizioni oftalmiche in forma di gel acquosi
PCT/EP2000/006062 WO2001001959A1 (en) 1999-07-01 2000-06-29 Ophthalmic compositions in form of aqueous gels

Publications (2)

Publication Number Publication Date
DE60002719D1 true DE60002719D1 (de) 2003-06-18
DE60002719T2 DE60002719T2 (de) 2003-10-09

Family

ID=11383262

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60002719T Expired - Lifetime DE60002719T2 (de) 1999-07-01 2000-06-29 Ophthalmische zusammensetzungen in form wässriger gele
DE1189595T Pending DE1189595T1 (de) 1999-07-01 2000-06-29 Ophthalmische zusammensetzungen in form wässriger gele

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1189595T Pending DE1189595T1 (de) 1999-07-01 2000-06-29 Ophthalmische zusammensetzungen in form wässriger gele

Country Status (10)

Country Link
EP (1) EP1189595B1 (de)
AT (1) ATE240094T1 (de)
AU (1) AU5980200A (de)
DE (2) DE60002719T2 (de)
DK (1) DK1189595T3 (de)
ES (1) ES2172485T3 (de)
HK (1) HK1042437B (de)
IT (1) ITMI991453A1 (de)
PT (1) PT1189595E (de)
WO (1) WO2001001959A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527807B2 (en) 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
US7045121B2 (en) 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
WO2004009056A1 (en) * 2002-07-23 2004-01-29 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
PL1654002T5 (pl) 2003-08-07 2014-06-30 Allergan Inc Kompozycje do dostarczania środków terapeutycznych do oczu
CN100360132C (zh) * 2003-08-25 2008-01-09 成都三明药物研究所 一种用于眼部的抗病毒药物组合物及其制备方法
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US8968781B2 (en) 2005-04-29 2015-03-03 Cubist Pharmaceuticals, Inc. Therapeutic compositions
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US7842714B2 (en) 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
JP2010104632A (ja) * 2008-10-31 2010-05-13 Hoya Corp ゲル化能を有する眼科用組成物
WO2011068872A2 (en) 2009-12-03 2011-06-09 Alcon Research, Ltd. Carboxyvinyl polymer-containing nanoparticle suspension
ITMI20122002A1 (it) * 2012-11-26 2014-05-27 Farmacologico Milanese Srl Lab Preparazioni farmaceutiche liquide stabilizzate
EP3442481B1 (de) 2016-04-13 2023-06-28 Avedro, Inc. Systeme zur abgabe von arzneimitteln an ein auge
CN115969776B (zh) * 2023-02-06 2023-08-29 湖南九典制药股份有限公司 氟比洛芬钠凝胶组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947573A (en) * 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
SE8005321L (sv) * 1979-07-31 1981-02-01 Lion Corp Oral komposition
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
FR2699081B1 (fr) * 1992-12-11 1995-04-07 Lvmh Rech Utilisation d'un extrait de Simaba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue.
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol

Also Published As

Publication number Publication date
EP1189595A1 (de) 2002-03-27
ATE240094T1 (de) 2003-05-15
DE60002719T2 (de) 2003-10-09
EP1189595B1 (de) 2003-05-14
ES2172485T1 (es) 2002-10-01
PT1189595E (pt) 2003-08-29
WO2001001959A1 (en) 2001-01-11
ES2172485T3 (es) 2004-02-01
ITMI991453A0 (it) 1999-07-01
AU5980200A (en) 2001-01-22
ITMI991453A1 (it) 2001-01-01
HK1042437B (zh) 2003-08-22
HK1042437A1 (en) 2002-08-16
DK1189595T3 (da) 2003-09-15
DE1189595T1 (de) 2002-10-17

Similar Documents

Publication Publication Date Title
DE60002719D1 (de) Ophthalmische zusammensetzungen in form wässriger gele
PT946143E (pt) Composicao gelificada a base de nitro-imidazole.
MY129356A (en) Electrospun pharmaceutical compositions
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
NO20021013L (no) Vandig geldannet blanding som omfatter en blokk-kopolymer inkluderende minst en vannopplöselig blokk og en hydrofob blokk
GB2007091A (en) Ophthalmic composition
ES2162638T3 (es) Vehiculos de suministro de farmacos con gelificacion termica que contienen eteres de celulosa.
BR0014203A (pt) Formulações de suspensão tópicas contendo ciprofloxacina e dexametasona
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
DE69826684D1 (de) Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendungen
ATE60900T1 (de) Tensidepraeparate.
RS50089B (sr) Suspenzija ziprasidona
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
NO993066L (no) Ny behandling for leddinflammasjon
CO4700420A1 (es) Formulacion transdermica
ES2181763T3 (es) Formulaciones a base de fenbendazol.
RS50345B (sr) Vodena farmaceutska kompozicija koja sadrži ciklesonid
ATE254851T1 (de) Iod-herstellungszusammensetzung
SE9403905D0 (sv) New formulations
AR012356A1 (es) Composiciones depilatorias: preparacion y uso.
ES2152315T3 (es) Xamoneline tartrato.
ES2195405T3 (es) Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion.
IT1264546B1 (it) Composizione farmaceutica ad attivita' antiacida in forma di sospensione a base di gel di sucralfato
IT1283324B1 (it) Composizioni veterinarie a base di antibatterici per uso intramammario
IT1255476B (it) Glicerofosfoderivati farmacologicamente attivi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition